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Associations between self-efficacy and secondary health conditions in people living with 1 
spinal cord injury: a systematic review and meta-analysis  2 
 3 
Abstract  4 
Objective: To describe the association between self-efficacy and secondary health conditions 5 
in people living with spinal cord injury.  6 
Data sources: PubMed, Embase, the Cochrane library and CINAHL were systematically 7 
searched from database inception to September 2016.  8 
Study selection: Studies describing patients living with spinal cord injury in which self-9 
efficacy was measured by a standardized questionnaire and an association was made with 10 
somatic or psychological secondary health conditions.  11 
Data extraction: An independent extraction by multiple observers was performed based on 12 
the STROBE statements checklist. A meta-analysis concerning the association between self-13 
efficacy and secondary health conditions in people with spinal cord injury was performed if a 14 
minimum of 4 comparable studies were available.  15 
Data synthesis: Out of 670 unique articles screened, 22 met the inclusion criteria. Seven out 16 
of these 22 studies investigated associations between self-efficacy and somatic secondary 17 
health conditions. Only a trend towards an association between higher self-efficacy with less 18 
pain, fatigue, number of secondary health conditions and limitations caused by secondary 19 
health conditions was found. Twenty-one studies described the association between self-20 
efficacy and psychological secondary health conditions. All correlations of higher self-21 
efficacy with fewer depressive (18) and anxiety symptoms (7) were significant and meta-22 













to -0.399) respectively. A small number of studies (2) showed a trend towards a positive 24 
correlation between self-efficacy and quality of life.  25 
Conclusion: Self-efficacy is negatively associated with depressive and anxiety symptoms in 26 
spinal cord injury. Therefore self-efficacy seems an important target in the rehabilitation of 27 
patients living with spinal cord injury. More research is necessary to clarify the associations 28 
between self-efficacy and somatic secondary health conditions. Future research should also 29 
focus on different types of self-efficacy and their association with secondary health 30 
conditions. 31 
 32 
Keywords: Spinal Cord Injuries, Self-Efficacy, Rehabilitation, Complications, Quality of 33 
Life, Mental Health. 34 
 35 
Abbreviations:  36 
SHCs: secondary health conditions  37 
SCI: Spinal cord injury  38 
 39 
Introduction  40 
Spinal cord injury (SCI) is a highly disabling condition that affects many aspects of daily 41 
life.1,2 A variety of secondary health conditions (SHCs) contribute to the disability people 42 
living with SCI may experience.1,3 A secondary health condition is defined as: a condition that 43 
is causally related to a disabling condition (i.e., occurs as the result of SCI) and that can either 44 













be divided into somatic and psychological health problems. In a large Canadian survey of 46 
1549 community based people living with a traumatic SCI, the following somatic SHCs were 47 
most commonly reported within 12 months after discharge from the hospital: neuropathic pain 48 
(65%), sexual dysfunction (62%), spasticity (60%), urinary tract infections (58%), joint 49 
contractures (57%), shoulder problems (53%), bowel incontinence (51%), weight problems 50 
(48%), urinary incontinence (46%), pressure ulcers (33%), neurological deterioration (33%) 51 
and fatigue (32%).5 Psychological SHCs most commonly described in people living with SCI 52 
include depression, anxiety and poor quality of life.6,7 Depression in people living with SCI 53 
has a prevalence of 22.2% (ranging from 7-48% in different studies).6 This differs strongly 54 
from the prevalence in the general population of 3.2% and from the prevalence of depression 55 
in people with any chronic physical disease, ranging from 9.3 till 23%.8 It is estimated that 56 
27% (ranging from 15-32%) of people living with SCI develop an anxiety disorder.9 In 57 
comparison, the prevalence of anxiety disorders in the general population is estimated at 58 
7.3%.10 In SCI research most studies, however, measured depression and anxiety using self-59 
rating scales. These measurements reflect subjective mood rather than demonstrate the 60 
existence of a depressive or anxiety disorder.11 61 
SCI itself can have an impact on the participation of a person12 and SHCs may significantly 62 
enlarge this impact, including by effecting work.1,2 Having SHCs is also related to high health 63 
care utilization, lower quality of life and increased health care costs.13,14 This makes 64 
minimizing the occurrence and impact of SHCs an important target for the rehabilitation and 65 
the life-long care of people living with SCI. 66 
A recent review shows that health promotion and self-care of people living with SCI are of 67 
great importance in preventing SHCs.2 It has also been suggested that, in chronic disease, a 68 













assumption that better self-efficacy will lead to a better self-care which in turn may prevent 70 
SHCs. In the last decades, self-efficacy has gained interest in SCI research. Also in the theory 71 
of adjustment after SCI, as postulated in the Spinal Cord Injury Adjustment Model, self-72 
efficacy has a central role. Within this model enhanced self-efficacy is associated with 73 
positive adjustment in the future.16 Self-efficacy is described as: the belief that one can 74 
successfully execute the behavior required to produce the desired outcomes.17 Self-efficacy 75 
can be operationalized at different levels: general self-efficacy is the general belief about 76 
one's ability to cope with a variety of difficult situations in life;18 disease management self-77 
efficacy is the ability to manage situations associated with one's problems that arise from their 78 
disease;19 lastly, self-efficacy can be measured with respect to specific situations. Some 79 
examples of SCI-specific self-efficacy are: wheelchair-specific self-efficacy20,21 and pressure 80 
sore prevention self-efficacy.22 Most research regarding people living with SCI, focuses on 81 
the association between general self-efficacy or disease management self-efficacy with pain, 82 
depression and anxiety.23–40 83 
Systematic reviews in people with chronic pain41 and osteoarthritis42 have shown that self-84 
efficacy is an important factor in relation to SHCs. However, to our knowledge, no systematic 85 
review on the association between self-efficacy and SHCs in people living with SCI has been 86 
performed to date. Therefore the aim of this systematic review is to describe the evidence on 87 
the associations between self-efficacy and SHCs in people living with SCI. All types of self-88 
efficacy and both somatic and psychological SHCs will be discussed. It is hypothesized that a 89 
higher self-efficacy leads to a lower incidence or less burden of both somatic and 90 
psychological SHCs. 91 
Methods 92 













Four relevant electronic medical databases (PubMed, The Cochrane Library, CINAHL and 94 
Embase) were comprehensively searched from database inception to September 2016. All 95 
electronically available, published research regarding self-efficacy in relation to SHCs of 96 
people with SCI were taken into account. Terms included: spinal cord injury and several 97 
synonyms, self-efficacy and related terms (e.g. self-concept, self-esteem, locus of control), 98 
and SHCs described in the SCI literature.1–3,5,9,43–47 These terms were used to search in all 99 
available search fields. Search terms used are shown in the appendix. 100 
After duplicates were removed, two investigators, one with a psychological (TvD) and one 101 
with a medical (TC) professional background, independently screened the titles and abstract 102 
for eligibility. Studies were included if they met the following criteria: 1) Journal article 103 
published in English. 2) The study describes people living with an acquired SCI, traumatic or 104 
non-traumatic. 3) The target population of the study is aged sixteen years or older. 4) Self-105 
efficacy is measured using a standardized questionnaire. 5) A quantitative association with 106 
secondary health conditions is reported. The following exclusion criteria were used: 1) The 107 
study focused on people with cognitive disorders or malignant tumors. 2) The study is a 108 
systematic review or a case report. 3) The study does not separate the results of people living 109 
with SCI from people with other diagnoses (e.g. MS, cerebral palsy, chronic pain). Studies 110 
utilizing data from the same study groups are only included once into the systematic review. 111 
Cohen's kappa was calculated and used to assess inter-rater agreement on inclusion. To 112 
prevent selection bias, the differences were discussed until both investigators reached 113 
consensus. The remaining articles’ full-texts were further checked for the in- and exclusion 114 
criteria as described above. In addition, the reference lists from the selected articles were 115 
screened for other potentially eligible studies.  116 
Critical Appraisal 117 













independently assessed by both investigators using the STROBE checklist for cohort, case 119 
control and cross-sectional studies.48 The STROBE statements checklist consists of 22 items 120 
(with 12 additional sub items) which relate to the title, abstract, introduction, methods, results 121 
and discussion settings of an article.49 One item: “13(c): Consider use of a flow diagram” was 122 
excluded, for this could not be verified by the investigators reading the article. Omitting this 123 
item left a total of 33 items. Twenty-one items were given a dichotomous rating, 1 (present) 124 
or 0 (absent). The other twelve items were given a three-point rating, 2 (present), 1 (partially 125 
present) or 0 (absent). If an item was not applicable for that study, the maximum score was 126 
given. This was applicable for four items. The range of the quality score was 0-45. The scores 127 
from both investigators were then compared, and differences were discussed to reach 128 
consensus. 129 
Statistical analysis 130 
Outcome data was extracted from the selected studies. Bivariate Pearson’s correlation 131 
coefficients were the preferable statistics. A meta-analysis was performed if sufficient studies 132 
described a correlation between self-efficacy and a particular SHC or a measure of SHCs. No 133 
standards regarding the number of articles for a meta-analysis could be found and a minimum 134 
of four articles was deemed appropriate to perform a meta-analysis, if the used outcome 135 
measures were sufficiently similar (e.g., a validated screening measure for depression). 136 
Comprehensive Meta-Analysis Software (CMA)a was used.. Correlations were first 137 
transformed into Fisher’s Z-scores, to calculate the mean. This mean Fisher’s Z-score could 138 
then be transformed back into a correlation.50 95% Confidence Intervals and p-values were 139 
calculated by entering the correlations and its sample sizes into Comprehensive Meta-140 
Analysis. Because of the differences in study design between the studies, a random-effects 141 

















Selection of articles 147 
A total of 925 articles were found through searching the four electronic databases. After the 148 
removal of duplicates, a total of 665 articles were considered for inclusion. The intra- and 149 
interobserver agreement (Cohen’s kappa) on in/exclusion of a study between the two 150 
investigators was 0.38. The investigator with a medical background selected more studies 151 
than the investigator with a psychological background, resulting in an only fair level of 152 
agreement.53 All discrepancies were discussed, until consensus was reached. From the 665 153 
articles found in the search, 70 were selected for full text analysis, resulting in the exclusion 154 
of another 49 articles. Screening of the references of all full-texts revealed five additional 155 
possibly relevant articles. Of these five articles, one was deemed eligible and added to the 156 
systematic review. The PRISMA Flow Diagram,54 with reasons to exclude each full-text, is 157 
shown in Figure 1.  158 
STROBE checklists 159 
A total of 22 articles were included in the systematic review and were critically appraised 160 
using the STROBE checklist. Table 1 shows the scores awarded to each study. Scores varied 161 
from 27 to 41 points, with a mean score of 37. Individual item data of the STROBE checklist 162 
are summarized in figure 2. As this figure shows all the found articles in the review explained 163 
the scientific background (item 2), gave matching criteria (item 6), described subgroup 164 
analysis (if applicable) (item 12B), summarized follow-up time (if applicable) (item 14C), 165 













Item 16C), reported other analysis (if applicable) (item 17), summarized key results (item 18) 167 
and gave overall interpretation of the results (item 20). Non however described any sensitivity 168 
analysis (item 12E). All but one study only gave incomplete information about the limitations 169 
of the study and the magnitude of the bias (item 19).  170 
The self-efficacy scales used in the included studies, measure this concept on diverging 171 
levels; general self-efficacy (General Self Efficacy Scale); disease specific or disease 172 
management self-efficacy (Moorong Self Efficacy Scale, Chronic Disease Self-Efficacy 173 
Scale, Self-Efficacy for Managing Chronic Disease Scale and the Beliefs Scale); or a specific 174 
type of self-efficacy (Leisure Time Physical Activity Self-Efficacy Scale). 175 
Somatic SHCs 176 
A total of seven studies 25,27,29,34–36,55 described a correlation between self-efficacy and 177 
somatic SHCs. All significant and non-significant correlations between self-efficacy and 178 
somatic SHCs are depicted in Table 2. Somatic SHCs investigated in relation to self-efficacy 179 
were: pain, fatigue, amount of somatic SHCs and limitations caused by somatic SHCs. Pain 180 
was described in a variety of terms, including “pain”25,29,34,35, “pain intensity”25,27,34,35 and 181 
“pain interference”27,36. One study showed an association between self-efficacy and fatigue.25 182 
Finally, two articles showed a correlation between self-efficacy and  a total somatic SHCs 183 
score.27,55 One article used the Secondary Health Conditions Scale, which measures the 184 
experienced impact of SHCs,27 the other used a list of 18 preselected SHCs in a 185 
questionnaire.55 Pain and pain intensity did not meet the criteria set for a meta-analysis due to 186 
diverging outcome measures; questionnaires versus single numeric rating scales (see table 2). 187 
For pain interference, fatigue and number/impact of SHCs the number of studies did not meet 188 













Psychological SHCs 190 
A total of 21 studies described an association between self-efficacy and one or more 191 
psychological SHCs.23–40,56–58 Eighteen studies showed significant correlations between self-192 
efficacy and depression, varying from -0.32 to -0.74 (Table 3).23–40 One study gave 193 
correlations between self-efficacy and depression during initial rehabilitation and 3 months 194 
after discharge, on behalf of the homogeneity the latest is used in the meta-analysis.26 All 195 
studies used validated scales to measure self-efficacy and depression. Assuming that these 196 
scales measure the same underlying construct, a meta-analysis was performed. The mean 197 
correlation and the forest plot of this meta-analysis are shown in Figure 3. The 4 studies using 198 
a general self-efficacy scale had a mean correlation of -0.52. The 13 studies using a disease 199 
specific or disease management self-efficacy scale had a mean correlation of -0.57. The one 200 
study using a specific type of self-efficacy scale showed a correlation of -0.32.39  201 
The most studies in this review are cross-sectional of nature and used community dwelling 202 
patient with SCI. One study however investigated the correlation between self-efficacy and 203 
depression on different time intervals.26 That study  showed a nonsignificant correlation 204 
during rehabilitation, and the largest correlation found in this review three months post-205 
discharge (-0.74).26 Another study used the same scale in a  larger population of community 206 
dwelling people with SCI (60% > 4 years post injury). The correlation found in that study was 207 
more similar to that of the mean correlation (-0.58).23 The only other longitudinal study in this 208 
review, investigated the correlation between self-efficacy and quality of life.57 That study 209 
showed a change from 3 to 15 months of r=0.62 to r=0.47 respectively. 210 
Seven studies showed a correlation between self-efficacy and anxiety.27–30,33–35 The scales 211 
used to describe self-efficacy varied, but anxiety was measured using only two scales: the 212 













Stress Scale 21 (DASS-21, one article). The correlations found varied from -0.32 to -0.61 and 214 
were all significant. The mean correlation and the forest plot are shown in Figure 4.  215 
One final study showed an association between self-efficacy and psychological disorders, 216 
determined using the Mini International Neuropsychiatric Interview-Plus.56 These 217 
psychological disorders included: major depressive disorder, bipolar disorder, suicidality, 218 
post-traumatic stress disorder, generalized anxiety disorder, alcohol dependence and abuse 219 
disorder, drug dependence and abuse disorder and psychosis. The only association with self-220 
efficacy shown in that article was a non-significant Odds Ratio of 1.05 for the total number of 221 
psychological disorders. Due to the different outcomes and the low number of articles 222 
describing quality of life, affective/subjective disorder and psychological disorders, no meta-223 
analyses were performed. 224 
 225 
Correlations between self-efficacy and quality of life were described in two studies.40,57 One 226 
study used the Life Satisfaction Questions (2LS) (a 2-item scale with one question regarding 227 
the quality of life at this moment, and one about the quality of life now compared  to life 228 
before SCI) to measure life satisfaction,40 where the other used the Quality of Life Index.57 229 
Another study reported no correlations, but a significant regression coefficient of self-efficacy 230 




A systematic review was performed, resulting in 22 studies describing an association between 235 













variables, fatigue, amount of SHCs and impact of SHCs. These studies did not provide solid 237 
evidence of an association between self-efficacy and somatic SHCs. Only a trend towards a 238 
small negative correlation was found. Based on 21 studies describing an association between 239 
self-efficacy and psychological SHCs, a meta-analysis produced strong mean negative 240 
correlations between self-efficacy and both depression and anxiety.  241 
The strong mean negative correlations between self-efficacy with depression and anxiety are 242 
in accordance with those found in a systematic review in people with osteoarthritis and 243 
somewhat stronger than found in a review of people with chronic pain.41,42 While the study on 244 
people with osteoarthritis did not find evidence of a relation between self-efficacy and pain,42 245 
the study of people with chronic pain, did find a relation between self-efficacy and pain 246 
intensity.41  247 
In this review only few studies were found examining self-efficacy and somatic SHCs. Most 248 
of these studies focused on pain. Frequently reported somatic SHCs in the SCI literature, like 249 
pressure ulcers and urinary tract infections, are to our knowledge, never examined in relation 250 
with self-efficacy other than being part of a total SHCs score. The occurrence of somatic 251 
SHCs may increase with the aging of the SCI population,59 and with the shortening of initial 252 
rehabilitation programs for financial reasons.60,61 Such an increase of somatic SHCs will lead 253 
to a higher rate of physician and specialist utilization, emergency department visits and 254 
hospital readmissions. This underscores the importance of research into prevention of somatic 255 
SHCs and the possible role of enhancing self-efficacy in self-care of persons with SCI.  256 
This review showed limited indication that time since injury might moderate the association 257 
between  self-efficacy and psychological SHCs.26,57 One study found that at inpatient stay, 258 
disease-management self-efficacy was not significantly correlated to depression. However, 3 259 













using the same scale in community dwelling patients with SCIthe correlation is somewhat 261 
weaker.23 A longitudinal study using a general self-efficacy scale to investigate the 262 
association with quality of life, found a decrease in the correlation from 3 to 15 months.57 263 
This might suggest that the influence of self-efficacy on psychological SHCs changes over 264 
time.23,26,57 It might be expected that disease management self-efficacy will increase during 265 
inpatient rehabilitation, being a major target of the rehabilitation team. How it changes, and its 266 
impact over time on the association with depression, must be clarified in future research. 267 
General self-efficacy on the other hand is a trait variable that will not change much over time, 268 
its alteration on the impact of the association with psychological SHCs must also be subject 269 
for further research.   270 
 The forest plot on the meta-analysis of self-efficacy and depression shows that one study 271 
deviates the furthest from the mean.39 Its negative correlation (-0.32) was smaller than any 272 
other study, of which the correlations did not get above -0.40. An explanation for this 273 
difference might be the Leisure Time Physical Activity self-efficacy scale, which no other 274 
study used. Leisure time physical activity is an aspect of importance for people living with 275 
SCI functioning in society. The Leisure Time Physical Activity self-efficacy scale mostly 276 
focuses on the barriers to performing leisure time physical activities. This may be the reason 277 
that the association with psychological SHCs is less strong.39 278 
 279 
To date it is unclear if the type of self-efficacy scale used influences the associations found 280 
with SHCs. The studies included in this review used different self-efficacy scales, measuring 281 
diverging levels of self-efficacy. The mean correlation of general self-efficacy scales with 282 
depression was somewhat weaker than the mean correlation of a SCI specific - or disease 283 













Moorong Self-Efficacy Scale (10 out of 17).24,25,29–33,35,39 The studies in our review all used 285 
the Moorong Self-Efficacy Scale total score. The scale was developed with a two factor 286 
structure, although some discrepant findings have been reported.30,32,62,63 In a recently 287 
published study, however, the factor structure of the Moorong scale was reexamined, showing 288 
three factors: social function self-efficacy (e.g.: I can maintain contact with people who are 289 
important to me), personal function self-efficacy (e.g.: I can maintain my personal hygiene 290 
with or without help) and general self-efficacy (e.g.: When I see someone I would like to 291 
meet, I am able to make the first contact).64 The authors consider the first two to be SCI-292 
specific variables, whereas the latter is considered to be a general self-efficacy. The 293 
reexamining study of the Moorong Self-efficacy Scale showed that the different subscales all 294 
had strong correlations with physical health (including pain and vitality) and mental health 295 
(the positive equivalent of depression). The most distinct differences are found between the 296 
social functioning self-efficacy (r=0.59) and personal functioning self-efficacy (r=0.42) on the 297 
one hand and mental health on the other. The total Moorong score showed the strongest 298 
correlation (r=0.63) with mental health.64 In a systematic review concerning people with 299 
chronic pain the heterogeneity in the found relationships across studies was, among other 300 
things, based on the self-efficacy scale content.41 Future research is needed to differentiate 301 
between the different levels of self-efficacy and their relations to SHCs and whether these 302 
different levels of self-efficacy have a different effect on somatic versus psychological SHCs.  303 
 304 
The strong mean correlations found for self-efficacy with depression and anxiety trigger 305 
interest in the causal pathway of this effect. Peter et al.37 tested the Spinal Cord Injury 306 
Adjustment Model,16 proposing a multifactorial adjustment process in which biological, 307 













appraise their situation. In this model appraisal refers to the way a person perceives and 309 
interprets a stressful situation, like their disability. Peter et al.37 found that self-efficacy 310 
influences depressive symptoms indirectly via appraisals; self-efficacy relates to the way 311 
people appraise their disability, which in turn leads to more or less depressive symptoms. 312 
Sweet et al.39 proposed another mechanism, based on their study of Leisure Time Physical 313 
Activity self-efficacy. Their hypothesis is that Leisure Time Physical Activity self-efficacy is 314 
directly correlated to Leisure Time Physical Activity, which in turn is negatively correlated to 315 
depression. Finally van Leeuwen et al.40 found that self-efficacy has a direct pathway to 316 
mental health, as well as a mediated pathway through appraisals. These studies describe both 317 
a direct and an indirect effect of self-efficacy on SHCs. It is likely that the indirect effect is 318 
mediated through appraisals. Future research is needed to clarify the direct and indirect effect, 319 
through appraisals, of self-efficacy on SHCs. 320 
The relatively high scores on the STROBE can be explained by the fact that 20 out of the 22 321 
articles are published in the last ten years. In this last decade, many publishers use the 322 
STROBE or similar checklists. 323 
 324 
Strengths and limitations 325 
This is the first systematic review in people with SCI with respect to self-efficacy in relation 326 
to SHCs. The search used was extensive, and terms related to self-efficacy were included to 327 
avoid missing relevant studies. Also the reference lists of included studies were screened for 328 
additional articles, which accounted for one extra study included in the systematic review. 329 
The results of this review are representative for people living with SCI in the community. 330 














Unfortunately, in case of somatic SHCs not enough data was found to come to a grounded 333 
conclusion. Although associations between self-efficacy and pain were examined in six 334 
studies, due to the use of significantly different pain scales no meta-analysis could be 335 
performed. It was further impossible to include the non-significant correlations that were 336 
mentioned but not stated in one article.27  337 
As in every systematic review, there is the risk of publication bias. Non-significant results are 338 
less likely to be to publish, so there is a possibility this data is missed despite of our extensive 339 
literature search. This may result in an inflation of the effect size estimates. 340 
Clinical implications 341 
Enhancing self-efficacy has been described as a target in the rehabilitation of SCI. This can 342 
for instance be done by exercise, through improving physical condition and functional 343 
abilities,65 or by improving the self-management abilities through a creative way of 344 
thinking.66 Often the outcome discussed in studies focusing on self-efficacy relate to a 345 
person’s participation.67 Our study suggests that increasing self-efficacy can have a positive 346 
effect on depressive and anxious symptoms and probably on somatic SHCs. A widely used 347 
therapy for both depression and anxiety is Cognitive Behavioral Therapy.68 Within this 348 
tradition, explicitly adjusting the self-efficacy cognitions of people with SCI may be, based on 349 
this review, a very promising approach that should be the subject of further research.  350 
Conclusion 351 
Self-efficacy is negatively associated with depressive and anxiety symptoms in spinal cord 352 
injury in accordance with the hypothesis. Therefore self-efficacy seems an important target in 353 













More research is necessary to clarify the associations between self-efficacy and somatic 355 
SHCs. Future research should also focus on different types of self-efficacy and their 356 
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Table 1 – Characteristics of included studies 
Article Country Study design Population N= STROBE 
Munce (2016)
31



































































 Australia Cross-sectional Inpatient 47 41 
Nicholson-Perry (2009/II)
33
 Australia Cohort Outpatient 45 40 
Miller (2009)
30





 China Cross-sectional Outpatient 119 35 
Suzuki (2007)
53





































Table 2 – Correlations between self-efficacy and somatic SHCs 
Type of SHC Article N= SE-scale Outcome scale Value 
Pain Kilic (2013)
27
 60 MSES NRS (0-10) -0.27 
  Craig (2013)
23
 70 MSES SFMPQ -0.54* 
  Nicholson-Perry (2009/I)
32
 47 MSES PRSS -0.28 
  Nicholson-Perry (2009/II)
33
 45 MSES PRSS -0.46* 
Pain intensity Craig (2013)
23
 70 MSES PPI -0.45* 
  Geyh (2012)
25
 102 GSES BPI NS 
  Nicholson-Perry (2009/I)
32
 47 MSES NRS (0-10) -0.47* 
  Nicholson-Perry (2009/II)
33
 45 MSES NRS (0-10) -0.36 
Pain interference Geyh (2012)
25
 102 GSES BPI -0.24* 
  Pang (2009)
34
 49 SEMCD PIS -0.59* 
Fatigue Craig (2013)
23
 70 MSES CFS -0.54* 
General SHCs Geyh (2012)
25
 102 GSES SHCS-L -0.25* 
        SHCS-N NS 
  Suzuki (2007)
53
 270 BRFSS 18 selected SHCs -0.13* 
All Studies showed a correlation between self-efficacy and the outcome. 
Abbreviations: MSES, Moorong Self-Efficacy Scale; NRS, Numeric Rating Scale; SFMPQ, Short-Form 
McGill Pain Questionnaire; PRSS, Pain Response Self-Statements Scale; PPI, Present Pain Intensity; 
GSES, General Self-Efficacy Scale; BPI, Brief Pain Inventory; PIS, Pain Interference Score; SEMCD, 
Self-Efficacy for Managing Chronic Diseases; CFS, Chaulder Fatigue Scale; SHCS-L, Secondary 
Health Conditions Scale Limitations; SHCS-N, Secondary Health Conditions Scale Number; BRFSS, 
Behaviour Risk Factor Surveillance System. 
The 18 selected SHCs from Suzuki (2007)53 include: high or too low blood pressure, poor 
circulation (such as swollen or cold feet or hands, blood clots), contractures, diabetes, fatigue, 
injuries, osteoporosis, pressure sores, alcohol or other drug overuse/abuse, muscle spasms, 
urinary tract infection/bladder problems, yeast infections/vaginal infections, pneumonia, repetitive 
motion pain (carpal tunnel syndrome, shoulder pain), weight management/weight gain, chronic 
pain, stomach problems, and constipation or bowel problems. 
* P < 0.05 














Table 3 – Correlations between self-efficacy and psychological SHCs 
Type of SHC Article N= SE-scale Outcome scale Value 
Depression Munce (2016)
31
 99 MSES HADS-D -0.56* 
  Driver (2016)
24
 44 CDSES PHQ-9 -0.74* 
  Peter (2015)
35
 516 GSES HADS-D -0.54* 
  Craig (2014)
22
 107 MSES SF-36
a
 0.48* 
  Sweet (2013)
37
 395 LTPA-SE PHQ-9 -0.32* 
  Kilic (2013)
27
 60 MSES DASS-21 -0.63* 
  Craig (2013)
23
 70 MSES POMS -0.64* 
  van Leeuwen (2012)
38
 143 GSES SF-36
a
 0.52* 
  Geyh (2012)
25
 102 GSES HADS-D -0.57* 
  Bombardier (2012)
21
 244 CDSES PHQ-9 -0.58* 
  Pang (2009)
34
 49 SEMCD CESD-10 -0.46* 
  Nicholson-Perry (2009/I)
32
 47 MSES HADS-D -0.61* 
  Nicholson-Perry (2009/II)
33
 45 MSES HADS-D -0.59* 
  Miller (2009)
30
 162 MSES CESD-10 -0.54* 
  Middleton (2007)
29
 106 MSES SF-36
a
 0.41* 
  Kennedy (2006)
26
 35 GSES HADS-D -0.43* 
  Middleton (2003)
28
 36 MSES HADS-D -0.61* 
  Shnek (1997)
36
 80 BS CESD-10 -0.58* 
Anxiety Munce (2016)
31
 99 MSES HADS-A -0.32* 
  Kilic (2013)
27
 60 MSES DASS-21 -0.54* 
  Geyh (2012)
25
 102 GSES HADS-A -0.61* 
  Nicholson-Perry (2009/I)
32
 47 MSES HADS-A -0.52* 
  Nicholson-Perry (2009/II)
33
 45 MSES HADS-A -0.43* 
  Kennedy (2006)
26
 35 GSES HADS-A -0.45* 
  Middleton (2003)
28
 36 MSES HADS-A -0.58* 
Quality of Life van Leeuwen (2012)
38




  Mortenson (2010)
55
 93 GSES QLI (3 months) 0.62* 





 119 GSES IPWB -0.09
b 
Psychological disorders Craig (2015)
54
 88 MSES MINI-plus 1.05
c 
All studies except for a and b showed a correlation between self-efficacy and the outcome. 
Abbreviations: MSES, Moorong Self-Efficacy Scale; HADS-D, Hospital Anxiety and Depression Scale 
- Depression; CDSES, Chronic Disease Self-Efficacy Scale; PHQ-9, Personal Health Questionaire 9; 
GSES, General Self-Efficacy Scale; SF-36, Short Form 36; LTPA-SE, Leisure Time Physical Activity 
Self-Efficacy; DASS-21, Depression Anxiety and Stress Scale 21; POMS, Profile of Mood States; 
SEMCD, Self-Efficacy for Managing Chronic Diseases; CESD-10 Centre of Epidemiologic Studies 
Depression Scale; BS, Beliefs Scale; HADS-A, Hospital Anxiety and Depression Scale - Anxiety; 
QLI, Quality of Life Index; IPWB, Index of Personal Well-Being; MINI-plus, MINI International 
Neuropsychiatric Interview. 
* P < 0,05 
a the SF-36 describes mental health instead of depression. Therefore outcomes are positive instead 
of negative. For the meta-analysis, the effect direction was changed to negative. 
b hierarchical regression instead of correlation was used as outcome measure 














Figure 1 – PRISMA Flow Diagram 
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Figure 2. Reporting quality assessment with STROBE (N=22) 
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Figure 4 – Self-efficacy and Anxiety: forest plot 
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